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ABSTRACT 18 
Objective: To investigate the association between patients’ expectations and the actual use of 19 
custom-made orthopaedic shoes. 20 
Design: A prospective cohort study with internal comparison. 21 
Setting: Twelve orthopaedic shoe companies. 22 
Patients: During six months, consecutive patients who were provided with their first ever pair 23 
of orthopaedic shoes and aged 16 years or older were recruited. A total of 339 patients with 24 
different pathologies were included (response 67%). Mean (SD) age of the patients was 63 25 
(15) years, and 129 patients (38%) were male.  26 
Main measures: A practical and reproducible questionnaire, measuring: frequency of use of 27 
orthopaedic shoes, patients’ expectations and experiences of aspects of the usability of 28 
orthopaedic shoes, and communication about patients’ expectations.  29 
Results: Patients’ expectations were not associated with the use of orthopaedic shoes (p-30 
values range: .106 to .607), but the difference between expectations and experiences was (p-31 
values range: <.001 to .012). The expectations of patients who frequently used their 32 
orthopaedic shoes were in concordance with their experiences, whereas the expectations of 33 
patients who did not use their orthopaedic shoes were much higher than their experiences. 34 
There was no communication of patients’ expectations with the medical specialist or 35 
orthopaedic shoe technician in 34% and 25% of the patients respectively.  36 
Conclusions: In relation to the actual use of orthopaedic shoes, it is crucial that patients’ 37 
expectations are not much higher than their experiences.  38 
 39 
Key words: Patient Expectations; Utilization; Shoes; Medical Devices; Patient Satisfaction. 40 
41 
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INTRODUCTION 42 
 43 
Custom-made orthopaedic shoes are assistive technologies, prescribed to a wide variety of 44 
patients to prevent or diminish foot and/or ankle problems.[1] Orthopaedic shoes are 45 
frequently prescribed in, for example, England and Wales (200.000 pairs prescribed in 2000; 46 
52 million inhabitants)[2], and in the Netherlands (50.000 pairs prescribed in 2006; 16 million 47 
inhabitants).[3] For any assistive technology to be effective, it is essential that they are 48 
actually used, to maximise the potential to contribute to positive health benefits.  49 
The use of orthopaedic shoes has been associated with many aspects of its usability, 50 
which is “the extent to which a product can be used by specified users to achieve specified 51 
goals with effectiveness, efficiency, and satisfaction, in a specified context of use” 52 
(International Organization for Standardization (ISO), 9241-11). Positive experiences with the 53 
effectiveness (e.g. less pain) or the efficiency (e.g. comfortable shoes) of the orthopaedic 54 
shoes, or the satisfaction of the patient, have all been associated with more frequent use.[4-7] 55 
These associations have all been established retrospectively, three months to two years after 56 
delivery of the orthopaedic shoes.[4-7] Patients’ expectations have not been taken into regard, 57 
even though patients’ expectations can seriously affect the use of an assistive technology.[8-58 
10] 59 
Little is known about patients’ expectations of orthopaedic shoes. To the best of our 60 
knowledge, there is only one study; the authors concluded that the use of orthopaedic shoes 61 
could not be predicted based on expectations.[11] However, the experiences of the patients 62 
were not taken into regard in that study. When considering the evidence for research in 63 
assistive technologies in general, it has been stressed that the difference between expectations 64 
and experiences is associated with the use of an assistive technology, rather than the 65 
expectations.[8][9] Expectations which are in concordance with experiences promote use of 66 
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an assistive technology, and non use is higher when expectations are not met by 67 
experiences.[8][9] With the limited evidence available, more insight into the association 68 
between patients’ expectations and the actual use of orthopaedic shoes is needed.  69 
The aim of this study was to investigate the association between patients’ expectations 70 
and the actual use of orthopaedic shoes three months after delivery.  71 
 72 
METHODS 73 
 74 
Procedures 75 
During six months, patients were recruited by 12 orthopaedic shoe companies to participate in 76 
this study. A specially developed questionnaire consisting of a pre-part and a post-part was 77 
used.[12] During the visit where foot measurements were taken, the orthopaedic shoe 78 
technician handed the pre-part over to patients who gave written informed consent. Personal 79 
data of these patients were sent to the researchers. The pre-part had to be completed and 80 
returned to the researchers before actual delivery of the orthopaedic shoes. Three months after 81 
delivery of the orthopaedic shoes, the researchers sent the post-part to all patients who 82 
completed the pre-part.  83 
Patients who did not complete either the pre- or the post-part of the questionnaire 84 
within a month were contacted by telephone once by the researchers in order to ask for the 85 
reason of delay and possible problems, and were asked to complete the questionnaire. The 86 
procedures were approved by the local Medical Ethics Committee. 87 
 88 
Patients 89 
Consecutive patients of 12 orthopaedic shoe companies who were provided with their first 90 
ever pair of orthopaedic shoes were included during six months. Patients who were provided 91 
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with a subsequent pair of orthopaedic shoes were excluded, because there is a large difference 92 
between patients who receive orthopaedic shoes for the first time and patients who receive a 93 
subsequent pair of orthopaedic shoes, especially with regard to their expectations.[13]
 
Other 94 
inclusion criteria were: (i) 16 years of age or older; (ii) able to complete the questionnaire 95 
without help related to cognitive or physical impairments. 96 
 97 
Outcome measures 98 
We used the Monitor Orthopaedic Shoes, which is a practical and reproducible questionnaire 99 
that can be used for patients with a wide range of disorders.[12] The Monitor Orthopaedic 100 
Shoes consists of a pre-part and a post-part with multiple choice and visual analog scale 101 
questions. The pre-part was designed to measure the current situation, patients’ expectations 102 
of the most relevant aspects of the usability of their orthopaedic shoes, and the 103 
communication regarding their expectations with the medical specialist and the orthopaedic 104 
shoe technician. The post-part was designed to measure use and the experiences of the 105 
usability of their orthopaedic shoes, and to measure the difference between expectations and 106 
experiences. For the purposes of this study, the results concerning patients’ expectations and 107 
concerning the difference between expectations and experiences were used. 108 
Three categories of use of orthopaedic shoes were defined: frequent use (4-7 109 
days/week), occasional use (1-3 days/week), and non use (not using orthopaedic shoes). We 110 
further asked patients to indicate the average daily duration of use in hours. Use of 111 
orthopaedic shoes was not further specified into activities during which orthopaedic shoes 112 
were used or location of use (e.g. indoor vs. outdoor use). 113 
Within the domains of usability as defined by the ISO, the following aspects were 114 
measured: change in walking capacity, wound healing, change in pain, and change in sprains 115 
(domain effectiveness); fit of orthopaedic shoes, ease of walking with orthopaedic shoes, 116 
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weight of orthopaedic shoes (domain efficiency); cosmetic appearance of orthopaedic shoes 117 
(domain satisfaction).[4-7]  118 
The difference between expectations and experiences was obtained in two ways. For 119 
items in the domains effectiveness and satisfaction, the score on the post-part of Monitor 120 
Orthopaedic Shoes (experiences; range 0-100) was subtracted from the score on the pre-part 121 
of Monitor Orthopaedic Shoes (expectations; range 0-100). The score of the difference 122 
between expectations and experiences could range from -100 to 100; a negative score 123 
meaning that expectations were higher than experiences, a positive score vice versa.  124 
For items in the domain efficiency, the difference between expectations and 125 
experiences was directly asked in the post-part of the Monitor Orthopaedic Shoes. This was a 126 
deliberate choice during the development of the Monitor Orthopaedic Shoes. Experts (both 127 
orthopaedic shoe technicians and experienced patients) indicated that patients only have a 128 
general expectation that aspects of the efficiency of orthopaedic shoes will be good, since 129 
orthopaedic shoes are fully custom-made and based on an individual model cast of their foot. 130 
They also indicated that patients are very well capable of indicating after delivery if there was 131 
a difference between the expectations they had and their actual experiences. The score of this 132 
question (range 0-100) was adjusted, so that the score of the difference between expectations 133 
and experiences of items in the domain efficiency could range from -100 to 100 as well; a 134 
negative score meaning that expectations were higher than experiences, a positive score vice 135 
versa. 136 
 137 
Statistical analysis 138 
Differences between the three groups were assessed with a Chi-square test or Kruskal-Wallis 139 
test. The latter was used because of non-normal distribution of the data. Post-hoc analyses to 140 
assess differences between the groups separately were performed using a Mann-Whitney U 141 
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test, and by calculating the effect size with the formula (effect size = Z / √(n1+n2)). Data were 142 
analyzed using SPSS for Windows, version 16.0 (SPSS Inc. Chicago, Illinois, United States 143 
of America). 144 
 145 
RESULTS 146 
The patient flow is shown in Figure 1. Mean (SD) age of the 339 patients included in the 147 
study was 63 (15) years, and 129 patients were male (38%). Of these patients, 85 had diabetes 148 
mellitus, 60 rheumatoid arthritis, 237 an (unspecified) foot disorder, 23 a muscular disease, 149 
and 104 another disorder (e.g. cerebral vascular accident, spinal cord injury, psoriasis, leather 150 
allergy, and others). Disorders were indicated by patients themselves, and it was possible to 151 
indicate more than one disorder. Age and gender of the patients included in the study were 152 
comparable with the non-responders (patients who gave written informed consent but did not 153 
complete both parts of the questionnaire; mean (SD) age 59 (17) years and 41% male), and 154 
with all patients of the orthopaedic shoe companies to whom a first ever pair of orthopaedic 155 
shoes was provided in the same six months (data obtained via management of the orthopaedic 156 
shoe companies; mean (SD) age 63 (17) years and 39% male).  157 
------------- 158 
Insert figure 1 around here 159 
------------- 160 
We were able to contact 34 of the 51 patients who did not respond to the post part of 161 
the questionnaire. Reasons indicated for not responding were lack of interest (n=15), lack of 162 
time (n=10), not using OS and dissatisfied (n=3), not using OS because of change in medical 163 
situation (n=2), questionnaire missing in post (n=2), and no reason specified (n=2). 164 
Three months after delivery of orthopaedic shoes, 275 patients (81%) used orthopaedic 165 
shoes frequently (4-7 days/week), 43 patients (13%) used orthopaedic shoes occasionally (1- 166 
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3 days/week), and 21 patients (6%) did not use orthopaedic shoes. There were no significant 167 
differences between the patient characteristics of the three groups (Table 1). Patients who use 168 
their orthopaedic shoes frequently have a significantly higher daily duration of use than 169 
patients who use them occasionally (Table 1). 170 
------------- 171 
Insert table 1 around here 172 
------------- 173 
 There were no associations between patients’ expectations and the use of orthopaedic 174 
shoes three months after delivery (Table 2). In contrast, the difference between patients’ 175 
expectations and experiences was significantly associated with the use of orthopaedic shoes 176 
(Tables 3). The expectations were in concordance with the experiences for patients who used 177 
their orthopaedic shoes frequently, whereas expectations were much higher than experiences 178 
for patients who did not use their orthopaedic shoes; the differences between expectations and 179 
experiences for patients who used their orthopaedic shoes occasionally fell in between (Table 180 
3). 181 
------------- 182 
Insert tables 2 and 3 around here 183 
------------- 184 
 Respectively 112 (34%) and 83 (25%) patients reported no communication about their 185 
expectations with the medical specialist and the orthopaedic shoe technician in (Table 4). Of 186 
the patients who did report discussion of their expectations with the medical specialist and the 187 
orthopaedic shoe technician, respectively 115 (54%) and 142 (58%) patients reported higher 188 
expectations afterwards; 2 (1%) and 6 (2%) patients reported lower expectations after 189 
discussion (Table 4). In total, 272 (87%) patients indicated that they had input concerning the 190 
cosmetic appearance of their orthopaedic shoes. No differences were found between patients 191 
  Page 9 of 21 
who use their orthopaedic shoes frequently, occasionally, or not (p-value range: .226 to .917; 192 
results not shown). 193 
------------- 194 
Insert table 4 around here 195 
------------- 196 
 197 
DISCUSSION 198 
In this study, the association between patients’ expectations and the actual use of orthopaedic 199 
shoes was investigated. It was shown that there is no association between patients’ 200 
expectations and the use of orthopaedic shoes. In contrast, an association was found between 201 
the use of orthopaedic shoes and the difference between expectations and experiences: the 202 
expectations of patients who frequently used their orthopaedic shoes were in concordance 203 
with their experiences, whereas the expectations of patients who did not use their orthopaedic 204 
shoes were much higher than their experiences. Around one quarter of the patients reported 205 
that there was no communication of their expectations with the medical specialist or the 206 
orthopaedic shoe technician. In line with research regarding assistive technologies in general, 207 
this research implies that, for orthopaedic shoes to be used, it is crucial that patients’ 208 
expectations are not much higher than their experiences.[8][9][14][15]  209 
 210 
To place the current findings into perspective, it is necessary to first discuss some limitations 211 
of this study. The difference between expectations and experiences was obtained in two ways. 212 
This makes it difficult to compare the scores of the separate items, and might bias the results. 213 
However, in a study where the measurement approach of patients’ expectations was 214 
investigated, it was concluded that there are no differences between these two methods.[16] 215 
Further, the trends and the association with the use of orthopaedic shoes was the same for all 216 
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measured aspects, independent of the way they were obtained. Because patients’ expectations 217 
are not associated with use, we would recommend for research purposes to only measure the 218 
difference between expectations and experiences directly at follow-up, as this is less time-219 
consuming and overcomes the problem that patients only have general expectations for some 220 
aspects. 221 
Caution should be taken when interpreting the results concerning communication, as 222 
only a few aspects of communication were measured and no insight was obtained into ‘what’ 223 
was being communicated. Future studies using a qualitative approach may provide more in 224 
depth insight into the intricacies of the communication between patient and the orthopaedic 225 
shoe technician and medical specialist.[17]  226 
Another limitation is the small number of patients who did not use their orthopaedic 227 
shoes after three months. Such a low rate of non use is clearly a positive result from a clinical 228 
point of view. However, it makes comparison between the three groups harder because of the 229 
skewed distribution. Because the differences between the groups were rather large for all 230 
aspects, including more patients would in our opinion result in finding the same effects with 231 
larger effect sizes.  232 
A possible bias may have resulted from the 33% non-responders. However, 233 
characteristics of patients included in the study were comparable to all patients who were 234 
provided with a pair of orthopaedic shoes in that period and to the non-responders. Further, 235 
we phoned patients who did not respond to the post part to check if non-response was related 236 
to non-use or dissatisfaction. Only a few did not use their orthopaedic shoes and even less did 237 
not respond because of dissatisfaction; all other patients did use them and had reasons for not 238 
responding that were not related to the outcomes. If there is a bias from the non-responders, it 239 
is in our opinion only small.  240 
 241 
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This study has important implications for research and clinical practice. Future research 242 
should aim to find predictors of use, as patients’ expectations have no predictive value. 243 
Prediction of use is worthwhile, as this can save time and energy from patients, medical 244 
specialists, and orthopaedic shoe technicians. A possibility that has been proposed in a 245 
recently developed, but not yet validated, model for prediction of use of assistive 246 
technologies[18], is research based on sociological theories like the theory of planned 247 
behaviour [19] and the diffusion of innovations theory [20]. To validate this model and to find 248 
predictors of use, future research should be patient-centred and focus on the perceived relative 249 
advantage of orthopaedic shoes.[18]  250 
Concerning clinical practice, this study underlines the importance of patients’ 251 
expectations. This again stresses the shift that should be made in clinical practice, from a 252 
focus on the technical qualities of the orthopaedic shoes, to a patient-centred 253 
focus.[17][21][22] An orthopaedic shoe that is technically perfect, yet does not meet the 254 
patients’ expectations, will most likely not be used.[23-25] Both the medical specialist and the 255 
orthopaedic shoe technician should focus on exploring and understanding the expectations a 256 
patient has of his orthopaedic shoes. An estimate can then be made if these expectations will 257 
be met by the experiences that patient is likely to have. If not, adjustments can be made in 258 
time, which will then promote the use of the orthopaedic shoes. 259 
Communication is the only way in clinical practice to explore and understand patients’ 260 
expectations, and this communication has been shown to be important in relation to the latter 261 
use of the orthopaedic shoes.[10][17][22][24] Our finding that around one quarter of the 262 
patients reported no communication of their expectations with the medical specialist or the 263 
orthopaedic shoe technician indicates that a potential gap exists between what a clinician may 264 
be trying to communicate and what the patient actually perceives or understands. Awareness 265 
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of this gap, and subsequent improvements in communication, may promote the use of an 266 
assistive technology. 267 
 268 
CLINICAL MESSAGES 269 
- Patients’ expectations are not associated with the use of orthopaedic shoes, whereas 270 
the difference between expectations and experiences is. 271 
- Patients’ expectations were much higher than their experiences after delivery for 272 
patients who did not use their orthopaedic shoes. 273 
- There is little communication about patients’ expectations between the patient and the 274 
medical specialist or orthopaedic shoe technician. 275 
 276 
277 
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Table 1: Patient characteristics, categorized with regard to the frequency of use of their 367 
custom-made orthopaedic shoes 368 
  Frequent use 
(n = 275; 81%) 
Occasional use 
(n = 43; 13%) 
Non use 
(n = 21; 6%) 
p* 
Gender  Male 110 (40%) 16 (37%) 3 (14%) 
.061 
 Female 165 (60%) 27 (63%) 18 (86%) 
      
Age (years) Mean ± SD 63 ± 14 63 ± 17 63 ± 12 .998 
      
Main  Pain 147 (54%)  30 (70%)  12 (57%)  
NA
§
 
reason
†
 Wounds 25 (9%) 1 (2%)  0 (0%)  
 Foot deviation 62 (23%)  5 (12%)  4 (19%)  
 Leg length difference 7 (3%) 0 (0%)  2 (10%)  
 Other 34 (12%) 7 (16%)  3 (14%)  
       
General  Improved 51 (19%)  3 (7%)  6 (29%)  
NA
§
 health
‡
 No change 194 (71%) 34 (79%)  11 (52%)  
 Deteriorated 28 (10%)  5 (12%)  3 (14%)  
 Missing 2 (1%) 1 (2%)  1 (5%)   
         
Daily  >12 hours 65 (24%) 2 (5%) 
NA 
 
duration 8 – 12 hours 93 (34%) 1 (2%)  
of use 4 – 8 hours 83 (30%) 14 (33%) <.001ζ 
(hours / day) 1 – 4 hours 29 (11%) 20 (46%)  
 < 1 hour 1 (.5%) 6 (14%)  
 Missing 4 (.5%) 0 (0%)  
Note: Values are n (%) or otherwise as indicated. Frequent use = using orthopaedic shoes 4-7 369 
days/week; Occasional use = using orthopaedic shoes 1-3 days/week; Non use = not using 370 
orthopaedic shoes. *: The p-value for the differences between the three groups is shown. 
†
: 371 
The main reason for prescription of orthopaedic shoes was indicated by patients themselves. 
‡
: 372 
General health refers to the change in general health (not the feet specifically) between pre- 373 
and post-measurements.
 §
: A Chi-square test was not applicable because more than 25% of the 374 
cells had an expected count less than 5. 
ζ
: The p-value for the difference between frequent and 375 
occasional users only is shown, as this was not applicable for non users. 376 
377 
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Table 2: Patients’ expectations, categorized with regard to the frequency of use of their 378 
custom-made orthopaedic shoes 379 
 Frequent use 
(n = 275; 81%) 
Occasional use 
(n = 43; 13%) 
Non use 
(n = 21; 6%) 
p* 
Walking capacity     
 Will improve 171 (65%) 24 (56%) 13 (62%) 
.607  Will stay the same 89 (34%) 17 (40%) 8 (38%) 
 Will deteriorate 5 (2%) 2 (5%) 0 (0%) 
 Missing 10 0 0  
Wounds     
 Will heal 41 (84%) 8 (80%) 0 
NA 
 Will stay the same 8 (16%) 2 (20%) 0 
 No wounds 223 33 17  
 Missing 3 0 4  
      
Change in pain (skin)
†
 (n=120;16;6)
 ‡
 86 (71.5 ; 94) 86 (77 ; 95) 66.5 (58.75 ; 84.75) .166 
Change in pain (muscles)
†
 (n=182;28;8)
 ‡
 83 (72 ; 93) 82 (65.5 ; 91.75) 72.5 (66.75 ; 87) .334 
Change in sprains
†
 (n=111;15;3)
 ‡
 89 (78 ; 96) 86 (73 ; 92) 77 (70 ; 79) .106 
     
Cosmetics: patient’s opinion
§
 53 (47 ; 75) 52.5 (31.75 ; 71.25) 54 (31 ; 63) .511 
Cosmetics: other’s opinion     
 Very ugly or ugly 29 (11%) 8 (19%) 3 (14%) 
.333 
 Neutral 95 (35%) 12 (28%) 10 (48%) 
 Attractive or very attractive 31 (11%) 3 (7%) 1 (5%) 
 Do not know or missing 120 (44%) 20 (47%) 7 (33%) 
Note: Values are n (%) or Median (IQR); Frequent use = using orthopaedic shoes 4-7 380 
days/week; Occasional use = using orthopaedic shoes 1-3 days/week; Non use = not using 381 
orthopaedic shoes; *: The p-value for the differences between the three groups is shown; 
†
: 382 
Expected change in pain/sprains is shown, scores could range from 0 (much more 383 
pain/sprains) to 100 (much less pain/sprains); ‡: Not all patients had pain or sprains; therefore 384 
the n of patients for these questions is indicated, for each group respectively; 
§
: Scores could 385 
range from 0 (very ugly) to 100 (very attractive). 386 
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Table 3: The difference between patients’ expectations and experiences, categorized with regard to the frequency of use 387 
     Post-hoc analyses
ζ
 
 Frequent use 
(n = 275; 81%) 
Occasional use 
(n = 43; 13%) 
Non-use 
(n = 21; 6%) 
 Freq. – Non.  Freq. – Occ. Occ. – Non. 
p*  p
†
 ES p
†
 ES p
†
 ES 
Change in pain (skin)
‡ 
(n=120;16;6) -1.5 (-19 ; 10.75) -1 (-21.75 ; 4.5) -48.5 (-74.25 ; -17.25) .012  .003 .26 .622 .04 .022 .49 
Change in pain (muscles)
‡ 
(n=182;28;8) -2.5 (-19 ; 10) -8 (-45.75 ; 1.5) -47.5 (-58.75 ; -21.5) <.001  <.001 .25 .018 .16 .048 .33 
Change in sprains
‡ 
(n=111;15;3) 2 (-7 ; 12) -1 (-22 ; 12)  -25 (-61 ; 17) .544        
Cosmetic appearance
§
 1 (-12 ; 18) 3 (-25.75 ; 10) -20.5 (-41.25 ; -3.75) .004  <.002 .19 .144 .09 .047 .27 
Fit of orthopaedic shoes 58 (9 ; 82) 24 (-35 ; 52) -5 (-83.5 ; 40) <.001  .001 .20 <.001 .21 .116 .21 
Walking with orthopaedic shoes 58 (9 ; 84) 6 (-37 ;69) -86 (-91 ; -60) <.001  <.001 .38 .001 .19 <.001 .59 
Weight of orthopaedic shoes 0 (-34 ; 50) -28 (-75 ; 5) -64 (-82 ; -8) <.001  .001 .19 <.001 .20 .274 .04 
Note: Values are Median (IQR) or as indicated; Scores could range from -100 to 100; a negative score meaning expectations > experiences, a 388 
positive score meaning experiences > expectations; ES = Effect Size; Freq. = Frequent use = using orthopaedic shoes 4-7 days/week; Occ. = 389 
Occasional use = using orthopaedic shoes 1-3 days/week; Non. = Non use = not using orthopaedic shoes; *: The p-value of the difference 390 
between the three groups is shown; 
ζ
: Post-hoc analyses for the aspects that were significantly different between the three groups are shown.
†
: 391 
The p-value of the difference between the two groups is shown
 
; 
‡
: Not all patients had pain or sprains, therefore the n of patients for these 392 
aspects is indicated, for each group respectively; 
§: Patients’ own opinion of the cosmetic appearance of their orthopaedic shoes is shown.393 
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Table 4: Communication about patients’ expectations 394 
 n = 339 
Communication with medical specialist  
Quality of communication* 87 (73.5 ; 95) 
Communication about expectations  
 Yes 220 (66%)  
 No or cannot remember 112 (34%)  
 Missing 7  
Expectations after communication   
 Higher expectations 115 (54%)  
 Lower expectations 2 (1%)  
 No change 52 (25%)  
 Did not have expectations 42 (20%)  
 Missing 9  
Communication with orthopaedic shoe technician  
Quality of communication* 90 (78 ; 96.5) 
Communication about expectations  
 Yes 249 (75%)  
 No or cannot remember 83 (25%)  
 Missing 7  
Expectations after communication   
 Higher expectations 142 (58%)  
 Lower expectations 6 (2%)  
 No change 67 (27%)  
 Did not have expectations 37 (13%)  
 Missing 2  
Input concerning cosmetic appearance?   
 Yes 272 (87%) 
 No 41 (13%) 
 Missing 26  
Note: Values are Median (IQR) or n (%). *: Quality of communication is the patient’s opinion 395 
of how well the medical specialist or orthopaedic shoe technician listened, scores could range 396 
from 0 (listened very bad) to 100 (listened very well). 397 
398 
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Figure 1: Patient flow. OS = custom-made orthopaedic shoes. 399 
 400 
